Marta Murray joins as VP of Quality NA
To support the company’s recent expansion of operations in Durham, North Carolina in the US, MedPharm has appointed Marta Murray as Vice President of Quality North America.
Marta brings with her over thirty years of experience in Quality operations in both biotech and pharmaceutical companies and has had roles in Quality Control, Validation and QA as well as in manufacturing. She has held leadership roles for companies including Cambrex, Abbott, MedImmune, DPT and most recently Torrent Pharma. Marta will be responsible for advancing MedPharm’s Quality Systems in the US for GLP and cGMP operations in parallel with the company’s expansion plans.
“Martha brings a wealth of experience in establishing proven robust quality systems”, commented Eugene Ciolfi, MedPharm’s President and CEO. “As we expand operations in the US is crucial that our systems are scalable and fit for purpose and Marta’s extensive knowledge and leadership will key to ensuring the smooth and efficient transition of the quality systems as the company grows”, he added.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognized for their scientific rigor by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.